Page 62 - Binder2

Figure 4. Projection of the biologics market size from 2023 to 2033

This shift was intentional. Biologics were expensive, and
they needed patient and payer buy-in. 7 out of the 10
largest pharmacy companies in the US spent more money
on marketing than they did on research and development
in 2021, during the height of the Covid-19 pandemic.

From a business perspective that sounds counterintuitive.
To date there have been 704,753,890 Covid-19 cases.
Meanwhile biologic prescriptions make-up 2% of all
prescriptions.

So why?

You get over Covid-19 in about a week. Most vaccines are
only 2 or 3 doses a year per patient. It wasn’t the gold rush
the public thought it to be.

60